# Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia

> **NCT04264533** · PHASE2 · TERMINATED · sponsor: **ZhiYong Peng** · enrollment: 56 (actual)

## Conditions studied

- Vitamin C
- Pneumonia, Viral
- Pneumonia, Ventilator-Associated

## Interventions

- **DRUG:** VC
- **DRUG:** Sterile Water for Injection

## Key facts

- **NCT ID:** NCT04264533
- **Lead sponsor:** ZhiYong Peng
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-02-14
- **Primary completion:** 2020-03-02
- **Final completion:** 2020-03-29
- **Target enrollment:** 56 (ACTUAL)
- **Why stopped:** the study was started in the second half of the outbreak, and the number of qualifying COVID-19 patients decreased with the control of the epidemic so that we had to stop our trial before reaching the predefined sample size.
- **Last updated:** 2020-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04264533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04264533, "Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04264533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*